Home›People›Marc de Garidel
MG

Marc de Garidel

Director at Claris Biotherapeutics.

Director
Updated Nov 2, 2026·Latest SEC filing Aug 12, 2026·Suggest an edit

About Marc de Garidel

Marc de Garidel is a director at Claris Biotherapeutics.

Marc de Garidel first appears on SEC filings in 2021.

Experience

This experience comes from SEC filings. The years are when the filings name Marc de Garidel in the role, so the role may have started earlier or lasted longer.

Claris Biotherapeutics, Inc.
Director
2021 – 2026 · Half Moon Bay, CA
Develops eye treatments for people with sight-threatening corneal diseases.

Key Colleagues at Startups

The people Marc de Garidel works with at each company, as listed on that company's latest Form D.

Claris Biotherapeutics, Inc. · Form D/A, Aug 12, 2026
Brian Baum
Brian Baum
Chief Commercial Officer
MF
RD
Reza Dana
Director
Stephen Brady
Stephen Brady
President and Chief Executive Officer, director
Henry Rath
Henry Rath
Chief Business Officer
MH
Matt Hobson
Director
MD
Susan Orr
Susan Orr
Chief Medical Officer
Clarke Atwell
Clarke Atwell
Co-Founder and Chief Operating Officer

Sources

  1. SECClaris Biotherapeutics, Inc. Form D/A, filed Aug 12, 2026